Can-Fite BioPharma Ltd.
CANF
$1.20
-$0.03-2.44%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 0.86% | 0.00% | -- | -- |
| Total Depreciation and Amortization | 0.00% | 500.00% | 0.00% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -64.05% | 0.00% | -- | -- |
| Change in Net Operating Assets | 0.00% | 140.67% | 0.00% | -- | -- |
| Cash from Operations | 0.00% | 10.78% | 0.00% | -- | -- |
| Capital Expenditure | 0.00% | 75.00% | 0.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -166.67% | 0.00% | -- | -- |
| Cash from Investing | 0.00% | -166.75% | 0.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 0.00% | 84.21% | 0.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -75.96% | 0.00% | -- | -- |